Arginine’s roles and metabolic edge over guanidinoacetic acid
Arginine (Arg) plays a vital role in avian metabolism far beyond its involvement in creatine synthesis to provide rapid energy. It serves as a precursor of nitric oxide (NO), facilitating vasodilation, converts into ornithine and proline, and supports polyamine biosynthesis, protein synthesis, and collagen formation.
Arginine serves as a precursor of nitric oxide (NO), facilitating vasodilation, whereas guanidinoacetic acid (GAA) functions solely as a precursor in the creatine synthesis pathway. Since creatine is linked to energy homeostasis, its production is tightly regulated by the rate-limiting enzyme arginine:glycine amidinotransferase (AGAT). If GAA is supplemented in the diet, it may contribute to an excessive amount of creatine production in muscles. If GAA is unused, it has to be converted into creatinine, which must ultimately be excreted via urine, imposing additional metabolic costs in terms of energy and amino acid loss for the animal.
Unlike GAA, Arg not only supports controlled creatine synthesis but also fulfils a multitude of essential metabolic functions. Therefore, supplementation of broiler diets with Arg ensures metabolic balance, supports energy homeostasis, and avoids the inefficiencies and potential toxicity associated with excessive GAA intake.
Arginine and GAA requirements
Multiple studies have confirmed that optimal broiler performance is achieved when standardised ileal digestible (SID) arginine to lysine (Arg:Lys) ratios are maintained around 107-135% during the starter and grower phases. Under practical feed formulation, CJ BIO recommends arginine at 115% of the level of lysine for best performance in broilers.
Per se, there is no established nutritional requirement for GAA in animals, as it is endogenously synthesised from arginine and glycine metabolism, requiring methionine (Met).
Role of arginine in energy utilisation
Arginine improves the utilisation of available metabolisable energy (ME) through multiple metabolic pathways:
- Arginine enhances ME utilisation via nitric oxide (NO) production, which improves blood flow to peripheral and splanchnic tissues, thereby optimising oxygen and nutrient delivery.
- It promotes the secretion of growth hormone and insulin, which enhances anabolic processes and facilitates efficient nutrient assimilation.
- Arginine strengthens antioxidant defence mechanisms by increasing levels of glutathione and superoxide dismutase (SOD), thereby improving mitochondrial efficiency and, ultimately, cellular energy delivery.
- It supports lean mass accretion, reduces fat deposition, and improves gut morphology and barrier integrity, all of which contribute to enhanced nutrient absorption and net energy extraction from feed.
Figure: Roles of arginine in different metabolic pathways
Limitations on arginine-sparing paradigm
The arginine-sparing effect of guanidinoacetic acid (GAA) is conditional and cannot be considered metabolically equivalent to direct arginine supplementation:
- The conversion of GAA to creatine requires methyl groups per mole of creatine synthesised. If the diet barely meets the requirements for methyl donors such as methionine, choline, or betaine, the increased methylation demand may offset the net energy benefits of GAA supplementation.
- GAA does not participate directly in the metabolic pathways of nitric oxide (NO), polyamines, or proline. Under stress conditions, the physiological demand for arginine increases disproportionately, and even excess dietary GAA cannot meet these additional metabolic requirements.
- In diets marginally deficient in arginine, GAA supplementation fails to fully restore growth performance, indicating that the arginine-sparing effect of GAA is incomplete and cannot serve as a full replacement for arginine.
In a recent study, Verhelle and Saremi (2025) conducted a pair of performance trials in broilers using arginine-deficient diets and observed that GAA supplementation partially restored growth performance. This suggests that exogenous GAA can alleviate some of the arginine burden under severe arginine deficiency – an artificial condition that does not typically occur under normal commercial feeding practices. The authors estimated an Arg:GAA equivalence ratio of approximately 1:0.57, while a 1:0.77 or 1-1.49 ratio is argued. The reasons for these discrepancies and the underlying metabolic complexities remain to be elucidated.
Benefits of arginine in least-cost formulation compared to GAA
Under practical conditions, the inclusion of Arg depends on raw material costs, physiological requirements, and the prevailing price of Arg. By contrast, formulators are often required to force the inclusion of GAA into feed by fixing it at a minimum level of 0.6 g/kg of feed. Even though it may be more cost-effective to meet the animal’s Arg requirement through conventional raw materials, GAA supplementation can displace these ingredients, potentially leading to an imbalanced nutrient profile and reduced dietary flexibility factors that may ultimately increase formulation costs. Furthermore, Arg precisely fulfils a specific amino acid requirement in a direct and quantifiable manner, whereas GAA lacks clarity regarding its actual arginine-sparing effect, with estimates varying widely (e.g. 0.50, 0.77, or 1.49 per Arg unit).
